Fjarde AP Fonden Fourth Swedish National Pension Fund cut its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 91,708 shares of the medical research company’s stock after selling 612 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Thermo Fisher Scientific were worth $17,351,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently made changes to their positions in the company. Putnam FL Investment Management Co. raised its holdings in Thermo Fisher Scientific by 417.4% during the 1st quarter. Putnam FL Investment Management Co. now owns 18,558 shares of the medical research company’s stock valued at $2,850,000 after buying an additional 14,971 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in Thermo Fisher Scientific during the 1st quarter valued at $35,578,000. Marshall Wace North America L.P. bought a new stake in Thermo Fisher Scientific during the 1st quarter valued at $35,578,000. Tekla Capital Management LLC raised its holdings in Thermo Fisher Scientific by 61.6% during the 1st quarter. Tekla Capital Management LLC now owns 228,020 shares of the medical research company’s stock valued at $35,024,000 after buying an additional 86,900 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. raised its holdings in Thermo Fisher Scientific by 7.6% during the 1st quarter. Meiji Yasuda Asset Management Co Ltd. now owns 35,745 shares of the medical research company’s stock valued at $5,490,000 after buying an additional 2,522 shares during the last quarter. Institutional investors and hedge funds own 86.16% of the company’s stock.
In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.49% of the stock is owned by corporate insiders.
Thermo Fisher Scientific Inc (TMO) traded down $10.17 during trading hours on Tuesday, hitting $182.03. 3,926,700 shares of the stock were exchanged, compared to its average volume of 1,555,471. The stock has a market cap of $77,071.31, a P/E ratio of 21.12, a PEG ratio of 1.76 and a beta of 1.06. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc has a 12-month low of $139.88 and a 12-month high of $201.20.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company’s revenue was up 13.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.03 EPS. analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.